SCI, SCI-e İndekslerine Giren Uluslararası Yayınlanan Makaleler

  • Turkish Real Life Atrial Fibrillation in Clinical Practice: TRAFFIC Study. Karabay C. Y., Taşolar H., Ülgen Kunak A., Çap M., Astarcıoğlu M. A., Şen T., Kaplan M., Coşgun M. S., Vatansever Ağca F., Arslan U., et al. Anatolian journal of cardiology, cilt.28, ss.87-93, 2024.

  • SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion De Luca G., Algowhary M., Uguz B., Oliveira D. C., Ganyukov V., Zimbakov Z., Cercek M., Jensen L. O., Loh P. H., Calmac L., et al. ANGIOLOGY, cilt.74, sa.10, ss.987-996, 2023.

  • Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry Kayıkcioglu M., Başaran Ö., Doğan V., Mert K. U., Mert G. Ö., Özdemir İ. H., Rencüzoğulları İ., Karadeniz F. Ö., Tekinalp M., Aşkın L., et al. Journal of Clinical Lipidology, cilt.17, sa.6, ss.732-742, 2023.

  • Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry MERT G. Ö., Özlek B., Özlek E., Ağuş H. Z., Tekinalp M., Kahraman S., Çil C., Çelik O., Başaran Ö., Doğan V., et al. Anatolian Journal of Cardiology, cilt.27, sa.9, ss.539-548, 2023.

  • How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study. Başaran Ö., Doğan V., MERT K. U., Özlek B., Özlek E., Çelik O., Özdemir C. Ç. İ. H., Rencüzoğulları İ., Karadeniz F. Ö., Tekinalp M., et al. Anatolian journal of cardiology, cilt.27, sa.2, ss.78-87, 2023

  • RELATIONSHIP BETWEEN LEFT ATRIAL FUNCTIONS AND AMBULATORY BLOOD PRESSURE VARIABILITY IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTIONMurat S., Murat B., Yalvac H. E., Dural M., Mert K. U., Cavusoglu Y. KARDIOLOGIYA, cilt.63, sa.1, ss.48-53, 2023.

  • Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 Registry De Luca G., Algowhary M., Uguz B., Oliveira D. C., Ganyukov V., Zimbakov Z., Cercek M., Jensen L. O., Loh P. H., Calmac L., et al. JOURNAL OF CLINICAL MEDICINE, cilt.11, sa.22, 2022.

  • Myocarditis After Vaccination Canakci M. E., Mert K. U., Aydin N. PREHOSPITAL AND DISASTER MEDICINE, cilt.37, sa.5, ss.716-717, 2022.

  • Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry De Luca G., Nardin M., Algowhary M., Uguz B., Oliveira D. C., Ganyukov V., Zimbakov Z., Cercek M., Okkels Jensen L., Loh P. H., et al. RESPIRATORY RESEARCH, cilt.23, sa.1, 2022.

  • Blood pressure variability and left atrial abnormalities in patients with heart failure and preserved ejection fraction Murat S., Yalvac H. E., Murat B., MERT K. U., Cavusoglu Y. EUROPEAN JOURNAL OF HEART FAILURE, cilt.24, ss.21-22, 2022.

  • Ventricular arrhythmia ablation in patients with mitral valve surgery DURAL M., MERT K. U., GÖRENEK B. Journal of Cardiovascular Electrophysiology, cilt.33, ss.1346, 2022.

  • Comparison of the prognostic value of neutrophil to lymphocyte ratios at different time points in patients with ST segment elevation myocardial infarction by five-year follow-up Mert G. O., DURAL M., MERT K. U., BİLGİN M., GÖRENEK B. Kuwait Medical Journal, cilt.54, sa.2, ss.163-171, 2022.

  • Does it work for atrial high-rate episodes? MERT G. Ö., MERT K. U., GÖRENEK B. PACE - Pacing and Clinical Electrophysiology, cilt.45, sa.5, ss.708, 2022.

  • COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction De Luca G., Algowhary M., Uguz B., Oliveira D. C., Ganyukov V., Zimbakov Z., Cercek M., Jensen L. O., Loh P. H., Calmac L., et al. HEART, cilt.108, ss.458-466, 2022

  • What to do with device-detected atrial high-rate episodes: Summary of the evidences Özge G. Ö., Kepez A., Uğur K. U., Görenek B. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.45, sa.2, ss.250-261, 2022.

  • Fragmented QRS formation in nonhypertensive acromegaly patients DURAL M., YORULMAZ G., MERT K. U., MURAT S. Turkish Journal of Medical Sciences, cilt.52, sa.4, ss.1413-1414, 2022.

  • Clinical characteristics and in-hospital outcomes of COVID-19 patients with history of heart failure: a propensity score-matched study. Murat B., Murat S., Mert K. U., Bilgin M., Cavusoglu Y. Acta cardiologica, cilt.77, sa.1, ss.37-44, 2022

  • Contemporary Management of Severe Symptomatic Aortic Stenosis Eugène M., Duchnowski P., Prendergast B., Wendler O., Laroche C., Monin J., Jobic Y., Popescu B. A., Bax J. J., Vahanian A., et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, cilt.78, sa.22, ss.2131-2143, 2021.

  • A critical warning: Diltiazem or Metoprolol in atrial fibrillation with rapid ventricular response. Babayiğit E., Mert K. U. The American journal of emergency medicine, cilt.50, ss.574, 2021

  • SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality? Babayiğit E., Mert K. U., Görenek B. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, cilt.23, ss.1150, 2021.

  • Letter to the Editor regarding article "J point elevation in high precordial leads associated with risk of ventricular fibrillation". Karakuş A., Mert K. U., Görenek B. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, cilt.26, 2021.

  • Management of LDL-cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real-life evidence of Under-treatment from the EPHESUS registry. Mert K. U., Başaran Ö., Mert G. Ö., Doğan V., Rencüzoğulları İ., Özlek B., Cinier G., Şenol U., Çelik O., Özlek E., et al. European journal of clinical investigation, cilt.51, sa.7, 2021.

  • Does Catheter ablation for Premature Ventricular Contractions remain unsuccessful in Arrhythmogenic Right Ventricular Cardiomyopathy? Babayiğit E., Karadeniz A., Mert K. U., Görenek B. Journal of cardiovascular electrophysiology, cilt.32, 2021.

  • Assesment of Cerebral Blood Flow Velocities with Transcranial Doppler Ultrasonography in Heart Failure Patients with Reduced Ejection Fraction. Babayiğit E., Murat S., Mert K. U., Çavuşoğlu Y. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, cilt.30, sa.5, ss.105706, 2021.

  • Evaluation of ventricular arrhythmias without considering ischemia. Mert G. Ö., Mert K. U., Görenek B. Journal of cardiovascular electrophysiology, cilt.32, sa.5, ss.1518, 2021.

  • Man With Syncope. Canakci M. E., Cure R., Sevik Ö. E., Mert K. U., Acar N. Annals of emergency medicine, cilt.77, sa.4, 2021.

  • A statistical perspective to the QTc interval in the treatment of COVID-19. Mert K. U., Turk U. O., Gorenek B. Journal of electrocardiology, cilt.66, ss.48, 2021

  • Genetic variants associated with atrial fibrillationand long-term recurrence after catheter ablation for atrial fibrillation in Turkish patients. Ulus T., Dural M., Meşe P., Yetmiş F., Mert K. U., Görenek B., Çilingir O., Erzurumluoglu Gökalp E., Arslan S., Artan S., et al. Anatolian journal of cardiology, cilt.25, sa.2, ss.129-138, 2021.

  • Assessment of fragmented QRS formation and its relationship with left ventricular hypertrophy in nonhypertensive acromegaly patients Dural M., Yorulmaz G., Alagüney E. S., Mert K. U., Çamli E., Kalkan A. T., Akalin A., Kebapçi M. N., Yilmaz A. S., Murat S., et al. TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.5, ss.2437-2444, 2021.

  • The association of exaggerated hypertensive response to exercise and beta-blockers use in hypertensives.Mert K. U., ŞENER E., Yilmaz A. S., Mert G. Ö., Yetmis F., Dural M., Babayigit E., Murat S., ÇAVUŞOĞLU Y., ULUS T., et al. Clinical and experimental hypertension (New York, N.Y. : 1993), cilt.42, sa.8, ss.707-713, 2020.

  • Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic: A nationwide study Erol M. K., Kayikcioglu M., Kilickap M., Guler A., Yildirim A., Kahraman F., Can V., Inci S., Baysal S. S., Er O., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.24, sa.5, ss.334-348, 2020.

  • Is caval index an appropriate tool for predicting hypovolemia in stroke. Ozakin E., Mert K. U. The American journal of emergency medicine, cilt.38, ss.2482, 2020.

  • Atrial fibrillation and atrial flutter ablation using mirror image in a patient with dextrocardia with situs inversus ULUS T., Dural M., ŞENER E., AL A., Mert K. U., GÖRENEK B. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.24, sa.4, ss.282-284, 2020.

  • Do nitrates improve survival on acute heart failure? Babayigit E., Mert K. U. AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.38, sa.9, ss.1951, 2020.

  • Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey Erol M. K., Kayikcioglu M., Kilickap M., Arin C. B., Kurt I. H., Aktas I., Gunes Y., Ozkan E., ŞEN T., Ince O., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.24, sa.1, ss.43-53, 2020.

  • Research update for articles published in EJCI in 2017 Arellano-Orden E., Bacopoulou F., Baicus C., Bonfrate L., Broadbent J., Buechler C., Carbone F., Charmandari E., Davis G. R., Dullaart R. P. F., et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, cilt.49, sa.10, 2019.

  • Contemporary Presentation and Management of Valvular Heart Disease The EURObservational Research Programme Valvular Heart Disease II Survey Iung B., Delgado V., Rosenhek R., Price S., Prendergast B., Wendler O., De Bonis M., Tribouilloy C., Evangelista A., Bogachev-Prokophiev A., et al. CIRCULATION, cilt.140, sa.14, ss.1156-1169, 2019.

  • The reasons of poor lipid target attainment for secondary prevention in real life practice: Results from EPHESUS Mert G. Ö., Basaran O., Mert K. U., DOĞAN V., Ozlek B., Celik O., Ozlek E., Cil C., Ozdemir I. H., RENCÜZOĞULLARI İ., et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.73, sa.9, 2019.

  • Oral Anticoagulation in Atrial High Rate Episodes Dural M., Mert K. U., GÖRENEK B. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, cilt.28, sa.9, ss.2588, 2019.

  • Risk stratification and timing for invasive approach in patients with non-STEMI Mert K. U., Mert G. Ö. AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.37, sa.9, ss.1792-1793, 2019.

  • Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry Ozlek B., Ozlek E., Agus H. Z., Tekinalp M., Kahraman S., Celik O., Cil C., Basaran O., DOĞAN V., Kaya B. C., et al. BALKAN MEDICAL JOURNAL, cilt.36, sa.4, ss.235-244, 2019.

  • Gerbode defect: A rare complication of infective endocarditis Mert G. Ö., Dural M., Gorenek B., Mert K. U. JOURNAL OF POSTGRADUATE MEDICINE, cilt.65, sa.3, ss.184-185, 2019.

  • Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study Ozlek B., Ozlek E., Kahraman S., Tekinalp M., Agus H. Z., Celik O., Cil C., DOĞAN V., Basaran O., Kaya B. C., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.21, sa.5, ss.242-252, 2019

  • Heart failure patients with previous anterior myocardial infarction have a lower cerebral blood flowÇAVUŞOĞLU Y., Babayigit E., Dural M., Mert K. U., Gorenek B., Ulus T. EUROPEAN JOURNAL OF HEART FAILURE, cilt.21, ss.251-252, 2019.

  • Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy Dural M., Demir L., Babayigit E., Junushova B., Mert K. U., Ulus T., Çavuşoğlu Y., Yıldız B., Dincer M., Görenek B. JOURNAL OF ELECTROCARDIOLOGY, cilt.54, ss.5-9, 2019.

  • Cerebral blood flow is lower in heart failure patients with reduced ejection fraction who have atrial fibrillation Babayigit E., ÇAVUŞOĞLU Y., Dural M., Mert K. U., Ulus T., Gorenek B. EUROPEAN JOURNAL OF HEART FAILURE, cilt.21, ss.535-536, 2019.

  • Clinical features of heart failure with mid-range and preserved ejection fraction in octogenarians: Ozlek B., Ozlek E., Tekinalp M., Kahraman S., Agus H. Z., Celik O., Cil C., Kaya B. C., RENCÜZOĞULLARI İ., Mert K. U., et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.73, sa.4, 2019.

  • Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey Gok G., ZOGHİ M., SİNAN Ü. Y., Kilic S., Tokgozoglu L., Sumerkan M. C., Emren V., Bekar L., Cersit S., Tunc E., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.21, sa.4, ss.196-205, 2019.

  • Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study Ozlek B., Ozlek E., Agus H. Z., Tekinalp M., Kahraman S., Cil C., Celik O., Basaran O., DOĞAN V., Kaya B. C., et al. EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.61, ss.88-95, 2019.

  • Beneficial effects of ivabradine in atrial or ventricular arrhythmias Mert K. U., ŞENER E., Mert G. Ö. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.41, sa.11, ss.1575, 2018.

  • Facts and details: Ivabradine in acute decompensated heart failure Mert K. U., Babayigit E., Mert G. Ö., ÇAVUŞOĞLU Y. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.271, ss.210, 2018.

  • Success predictor of cryoballoon ablation in atrial fibrillation: Left atrial volume vs area Mert G. Ö., Mert K. U., GÖRENEK B. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.270, ss.188, 2018.

  • The diagnostic challenge: Takotsubo cardiomyopathy vs. acute myocarditis Mert G. Ö., Radi F., Mert K. U. HEART & LUNG, cilt.47, sa.6, ss.646, 2018.

  • Comparison of acute management of atrial fibrillation in heart failure with unequal sized groups Mert G. Ö., Dural M., Mert K. U. AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.36, sa.9, ss.1693, 2018.

  • Noninvasive predictors of cardiac arrhythmias in bodybuilders Mert K. U., Ilguy S., Mert G. Ö., Dural M., Iskenderov K. REVISTA PORTUGUESA DE CARDIOLOGIA, cilt.37, sa.8, ss.693-701, 2018.

  • Prognostic relevance of left ventricle thrombus vs. ST elevation in Takotsubo syndrome Mert G. Ö., Mert K. U., Biteker M. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.258, ss.28, 2018.

  • Rationale, Design, and Methodology of the APOLLON trial: A comPrehensive, ObservationaL registry of heart faiLure with mid-range and preserved ejectiON fraction Ozlek B., Ozlek E., Celik O., Cil C., DOĞAN V., Tekinalp M., Agus H. Z., Kahraman S., Osken A., RENCÜZOĞULLARI İ., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.19, sa.5, ss.311-318, 2018.

  • Effects of heart rate reduction with ivabradine on the international ndex of erectile function (IIEF-5) in patients with heart failure Mert K. U., Dural M., Mert G. Ö., Iskenderov K., Ozen A. AGING MALE, cilt.21, sa.2, ss.93-98, 2018.

  • Fracture of the distal part of an implantable cardioverter-defibrillator lead two months after implantationDural M., Mert K. U., Eraslan S., Iskenderov K., ÇAVUŞOĞLU Y. KARDIOLOGIA POLSKA, cilt.76, sa.2, ss.472, 2018.

  • A Mexican Standoff: Mitral stenosis, mitral balloon valvuloplasty, Tp-e interval, Tp-e/QT and Tp-e/QTc ratios and sympathetic activity Replye/QTc ratios and sympathetic activity Reply Dural M., Mert K. U., Iskenderov K. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.18, sa.6, ss.437-438, 2017.

  • A Mexican standoff: Mitral stenosis, mitral balloon valvuloplasty, Tp-e interval, Tp-e/QT and tp- e/QTc ratios and sympathetic activity Dural M., Mert K. U., İskenderov K. Anatolian Journal of Cardiology, cilt.18, sa.6, ss.437-438, 2017.

  • Evaluation of Tp-e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with mitral valve stenosis before and after balloon valvuloplasty Dural M., Mert K. U., Iskenderov K. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.18, sa.5, ss.353-360, 2017.

  • Is electrical cardioversion doable in atrial fibrillation without transesophageal echocardiography? Mert K. U., Dural M., Mert G. Ö. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.247, ss.20, 2017.

  • Analysis of geographical variations in the epidemiology and management of non-valvular atrial fibrillation: results from the RAMSES registry Dogan V., Basaran O., Biteker M., Karadeniz F. O., Tekkesin A. I., Cakilli Y., Turkkan C., Hamidi M., Demir V., Gursoy M. O., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.18, sa.4, ss.273-280, 2017.

  • Questioning reliability of observational study Mert K. U., Dural M., Mert G. Ö. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.40, sa.9, ss.1046, 2017.

  • Successful management of iatrogenic retrograde dissection into the aortic root Mert K. U., Mert G. Ö., Dizman R. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.18, sa.3, ss.235-237, 2017.

  • Real-world stroke prevention strategies in nonvalvular atrial fibrillation in patients with renal impairmentMert K. U., Mert G. Ö., Basaran O., BETON O., DOĞAN V., Tekinalp M., Aykan A. C., Kalaycioglu E., Bolat I., Tasar O., et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, cilt.47, sa.6, ss.428-438, 2017.

  • Effects of creatine supplementation on cardiac autonomic functions in bodybuilders Mert K. U., Ilguy S., Dural M., Mert G. Ö., ÖZAKIN E. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, cilt.40, sa.6, ss.721-727, 2017.

  • PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER study) Basaran O., Basaran N. F., Cekic E. G., Altun I., Dogan V., Mert G. Ö., Mert K. U., Akin F., Soylu M. O., Sancar K. M., et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.23, sa.4, ss.384-391, 2017.

  • Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from RAMSES study Basaran O., Dogan V., Biteker M., Karadeniz F. O., Tekkesin A. I., Cakilli Y., Turkkan C., Hamidi M., Demir V., Gursoy M. O., et al. EUROPEAN JOURNAL OF INTERNAL MEDICINE, cilt.40, ss.50-55, 2017.

  • Electromagnetic interference of mobile phones: insight into heart rate variability Mert K. U., Dural M., Mert G. Ö., Iskenderov K. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.3, ss.248, 2017.

  • Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study Basaran O., Dogan V., Beton O., Tekinalp M., Aykan A. C., Kalaycioglu E., Bolat I., Tasar O., Safak O., Kalcik M., et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, cilt.43, sa.2, ss.157-165, 2017.

  • Cutaneous microvascular reactivity and aortic elasticity in coronary artery disease: Comparison ofthe laser Doppler flowmetry and echocardiography Cekic E. G., Basaran O., Basaran N. F., Elmas O., Dogan V., Mert G. Ö., Mert K. U., Altun I., Akin F., Biteker M. MICROVASCULAR RESEARCH, cilt.109, ss.19-25, 2017.

  • Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias Mert K. U., Mert G. Ö., Morrad B., Tahmazov S., Mutlu F., Çavuşoğlu Y. KARDIOLOGIA POLSKA, cilt.75, sa.8, ss.786-793, 2017.

  • Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study Biteker M., Basaran O., Dogan V., Beton O., Tekinalp M., Aykan A. C., Kalaycioglu E., Bolat I., TaSar O., Safak O., et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.41, sa.6, ss.711-717, 2016.

  • ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study) Basaran O., Beton O., Dogan V., Tekinalp M., Aykan A. C., Kalaycioglu E., Bolat I., Tasar O., Safak O., Kalcik M., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.10, ss.734-741, 2016.

  • Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study Dogan V., Basaran O., Beton O., Tekinalp M., Bolat I., Kalaycioglu E., Aykan A. C., Tasar O., Safak O., Kalcik M., et al. CORONARY ARTERY DISEASE, cilt.27, sa.6, ss.497-503, 2016.

  • Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study Basaran O., Dogan V., Beton O., Tekinalp M., Aykan A. C., Kalaycioglu E., Bolat I., Tasar O., Safak O., Kalcik M., et al. MEDICINE, cilt.95, sa.35, 2016.

  • What is your diagnosis? B. Free-floating thrombus Mert K. U., Mert G. Ö., Karabay C. Y., Kalayci A. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.16, sa.2, ss.141-142, 2016.

  • Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: an Update Biteker M., Mert K. U., Mert G. Ö. FRONTIERS IN MEDICINE, cilt.3, 2016.

  • Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure ÇAVUŞOĞLU Y., Mert U., Nadir A., MUTLU F., Morrad B., ULUS T. JOURNAL OF CARDIOVASCULAR MEDICINE, cilt.16, sa.9, ss.603-609, 2015.

  • Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study ÇAVUŞOĞLU Y., Korkmaz S., DEMİRTAŞ S., Gencer E., Sasmaz H., MUTLU F., GÜNEŞ H., Mert U. K., Ozdemir S., Kalayci S., et al. ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.15, sa.8, ss.611-617, 2015.

  • Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics Biteker M., Basaran O., Mert G. Ö., Dogan V., Mert K. U. BLOOD COAGULATION & FIBRINOLYSIS, cilt.26, sa.4, ss.477-478, 2015.

  • Ivabradine in cardiogenic shock: Fact or fiction? Mert K. U., Mert G. Ö., Altun I., Biteker M. HEART & LUNG, cilt.44, sa.2, ss.178, 2015.

  • Treatment of Kounis syndrome Dogan V., Mert G. Ö., Biteker F. S., Mert K. U., Biteker M. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.181, ss.133-134, 2015.

  • B-type natriuretic peptide in infective endocarditis Biteker F. S., Mert G. Ö., Mert K. U., Biteker M. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.31, ss.68, 2015.

  • Takotsubo cardiomyopathy or Kounis syndrome or both? Mert G. Ö., Biteker F. S., Mert K. U., Basaran O., Dogan V., Biteker M. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.179, ss.16, 2015.

  • Does ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: Parallax in significance Mert K. U., Mert G. Ö., Basaran O., Biteker M.INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.177, sa.2, ss.726, 2014.

  • Infective endocarditis prophylaxis in transcatheter aortic valve replacement Biteker F. S., Mert K. U., Mert G. Ö., Dogan V., Biteker M. INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.177, sa.3, ss.1066, 2014.

  • Kounis syndrome and antibiotics Biteker F. S., Dogan V., Mert K. U., Mert G. Ö., Biteker M. ANNALS OF SAUDI MEDICINE, cilt.34, sa.6, ss.556, 2014.

  • Levosimendan shows potential renoprotective effect in addition to a better hemodynamic profile over dobutamine in patients presenting with acute heart failure syndromes Cavusoglu Y., Gencer E., Mutlu F., Nadir A., Mert K. U., Morrad B., Eraslan S. EUROPEAN JOURNAL OF HEART FAILURE, cilt.16, ss.159-160, 2014.

  • Ivabradine treatment blunts dobutamine-induced increase in heart rate in patients with acute decompensated heart failure: a comparative study with beta-blocker therapy Cavusoglu Y., Mert K. U., Nadir A., Mutlu F., Gencer E., Ulus T. EUROPEAN JOURNAL OF HEART FAILURE, cilt.12, 2013.

  • Effects of levosimendan and dobutamine on systolic time intervals in patients with acute decompensated heart failure Cavusoglu Y., Nadir A., Mert K. U., Gencer E., Mutlu F., Ulus T. EUROPEAN JOURNAL OF HEART FAILURE, cilt.12, 2013.

  • Effectiveness of Cardiac Simulator on the Acquirement of Cardiac Auscultatory Skills of Medical StudentsBirdane A., Yazici H. U., AYDAR Y., Mert K. U., Masifov M., ULUS T., ÇAVUŞOĞLU Y., ATA N., Timuralp B. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, cilt.21, sa.6, ss.791-798, 2012.

Sonraki

Diğer Dergilerde Yayınlanan Makaleler